Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients-Reference-Cited by-同舟云学术

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Published:2013-02-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hodson Elisabeth M¹²,Ladhani Maleeka¹,Webster Angela C²³⁴,Strippoli Giovanni FM²⁴⁵⁶⁷,Craig Jonathan C²⁴

Affiliation:

1. The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145

2. The University of Sydney; Sydney School of Public Health; Sydney NSW Australia 2006

3. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

4. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead NSW Australia 2145

5. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy 70100

6. Mario Negri Sud Consortium; Department of Clinical Pharmacology and Epidemiology; Santa Maria Imbaro Italy

7. Diaverum; Medical-Scientific Office; Lund Sweden

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003774.pub4/fullpdf

Reference213 articles.

1. Randomized trial comparing valacyclovir versus valganciclovir prophylaxis of cytomegalovirus in renal transplant recipients Australian and New Zealand Clinical Trials Registry ACTRN 12610000016033

2. Lymphocyte function during valacyclovir and valganciclovir cytomegalovirus prophylaxis in renal transplant recipients [abstract];Reischig;American Journal of Transplantation,2010

3. Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients;Reischig;Antiviral Therapy,2011

4. Oral ganciclovir (CytoveneR) effectively prevents cytomegalovirus (CMV) infection in renal transplant patients [abstract];Ahsan;Journal of the American Society of Nephrology,1996

5. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients;Ahsan;Clinical Transplantation,1997

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients;Cochrane Database of Systematic Reviews;2024-05-03

2. Risk factors and outcomes of cytomegalovirus infection in the intensive care unit;The Journal of Infection in Developing Countries;2024-04-30

3. Infections in Heart and Lung Transplant Recipients;Infectious Disease Clinics of North America;2024-03

4. ОНОВЛЕНІ УЗАГАЛЬНЕНІ РЕКОМЕНДАЦІЇ З ЛІКУВАННЯ ГЕРПЕСВІРУСНИХ ІНФЕКЦІЙ ЛЮДИНИ;Journal of Dermatovenereology and Cosmetology named after N.A.Torsuiev;2024-02-08

5. Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation;Infection & Chemotherapy;2024